[THE INVESTOR] As of Apr. 28 01:40 P.M., Daewon Pharmaceutical declined 2.66%, compared with yesterday, to 21,950 won(US$ 19.31). It had increased 7.33% through the past month. Standard deviation, the volatility index for stock price, was 2.1% on the same period of time over one month.

Compared with its close competitors within the same industry, KOSPI, the monthly earnings rate of Daewon Pharmaceutical was the highest and its volatility over one month was also the highest. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 3.4. 

The return-on-risk is below the industrial mean, 3.6, and thus the industrial comparison performance was not so good. 

By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.